chr5-91150218-G-A
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_032119.4(ADGRV1):c.18621G>A(p.Glu6207Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000212 in 1,554,880 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_032119.4 synonymous
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.0000592  AC: 9AN: 151924Hom.:  0  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.000101  AC: 20AN: 197918 AF XY:  0.0000935   show subpopulations 
GnomAD4 exome  AF:  0.0000171  AC: 24AN: 1402838Hom.:  0  Cov.: 34 AF XY:  0.0000173  AC XY: 12AN XY: 692686 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000592  AC: 9AN: 152042Hom.:  0  Cov.: 31 AF XY:  0.0000135  AC XY: 1AN XY: 74346 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not specified    Benign:1 
p.Glu6207Glu in exon 88 of GPR98: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence. It has been identified in 0.1% (6/5462) of East Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; dbSNP rs543269561). -
ADGRV1-related disorder    Benign:1 
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not provided    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at